Inicio › Esteatosis hepática › Texas
Ensayos clínicos de Esteatosis hepática en Texas
20 estudios sobre Esteatosis hepática buscan participantes en Texas.
Ciudades en Texas
- San Antonio17 estudios
- Austin13 estudios
- Houston13 estudios
- Dallas9 estudios
- Round Rock7 estudios
- Brownsville7 estudios
- Sugar Land6 estudios
- Fort Worth6 estudios
- Arlington6 estudios
- Waco6 estudios
- Grand Prairie5 estudios
- Edinburg4 estudios
- Pasadena4 estudios
- Carrollton4 estudios
- The Woodlands4 estudios
- Corpus Christi3 estudios
- League City3 estudios
- Lewisville3 estudios
Texto oficial del estudio (inglés)
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Arlington
- GSK Investigational Site, Austin
- GSK Investigational Site, Bellaire
- y 5 más
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 30 sept 2026 · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Arlington
- GSK Investigational Site, Austin
- GSK Investigational Site, Bellaire
- y 4 más
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 30 sept 2026 · NCT07701993A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- American Research Corporation, Austin
- Advanced Medical Trials, Georgetown
- American Research Corporation at The Texas Liver Institute, San Antonio
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 29 sept 2026 · NCT07527910A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- American Research Corporation, Austin
- Pinnacle Clinical Research - Austin, Austin
- Methodist Dallas Medical Center, Dallas
- y 5 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- IMA Clinical Research Austin, Austin
- American Research Corporation, Austin
- Pinnacle Clinical Research, Austin
- y 26 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Arlington
- Akero Clinical Study Site, Austin
- Akero Clinical Study Site, Austin
- y 28 más
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
- GSK Investigational Site, Brownsville
- y 12 más
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 17 sept 2026 · NCT07221188A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Pinnacle Clinical Research, Austin
- Bellaire Clinical Research, Bellaire
- South Texas Research Institute (STRI) - Brownsville, Brownsville
- y 14 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 9 sept 2026 · NCT07288138A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Amarillo
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- y 21 más
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Amarillo
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- y 30 más
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06318169Quantifying Hepatic Mitochondrial Fluxes in Humans
- Texas Diabetes Institute - University Health System, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 17 ago 2026 · NCT05305287A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Arlington
- GSK Investigational Site, Austin
- GSK Investigational Site, Dallas
- y 4 más
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06613698A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Arlington
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
- y 16 más
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 jul 2026 · NCT07221227A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
- y 10 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 8 jul 2026 · NCT06920043A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
- GSK Investigational Site, San Antonio
ReclutandoFase 1
Edades de 18 a 70 · Todos los sexos · Actualizado el 9 jun 2026 · NCT07358546Evaluating the Pharmacokinetics and Safety of Miricorilant
- Site# 433, San Antonio
ReclutandoFase 1
Edades de 18 a 75 · Todos los sexos · Actualizado el 26 may 2026 · NCT07553663Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population
- Methodist Dallas Medical Center, Dallas
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 may 2026 · NCT06225193A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Pioneer Research Solutions, Houston
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 18 a 75 · Todos los sexos · Actualizado el 16 abr 2026 · NCT05648214NAFLD Clinical Care Pathway
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
ReclutandoSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 nov 2025 · NCT06671886Evaluation of Non-Invasive Tests for Metabolic Liver Disease
- First Surgical Hospital, Bellaire
- Endeavor Clinical Trials, San Antonio
ReclutandoEstudio observacional
Edades de 18 a 75 · Todos los sexos · Actualizado el 14 ago 2025 · NCT07122700De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.